A comparison of mutation and amplification-driven resistance mechanisms and their impacts on tumor recurrence.

Abstract excerpt

Tumor recurrence, driven by the evolution of drug resistance is a major barrier to therapeutic success in cancer. Tumor drug resistance is often caused by genetic alterations such as point mutation, which refers to the modification of a single genomic base pair, or gene amplification, which refers to the duplication of a region of DNA that contains a gene. These mechanisms typically confer varying degrees of...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Genomics
• Share to Mutation
• Share to Neoplasm Recurrence, Local